Correction to: Characterization of mesocolic adipose hyperplasia in a rat 2,4,6-trinitrobenzenesulfonic acid colitis model and comparison to creeping fat in Crohn disease [0.03%]
Correction to：2，4，6-三硝基苯磺酸鼠结肠炎模型中回结型肠系膜脂肪增生的特征及与克罗恩病潜行性脂肪增生对比研究
Published Erratum
Inflammatory bowel diseases. 2026 Apr 19:izag071. DOI:10.1093/ibd/izag071 2026
The prevalence of abdominal computed tomography imaging findings in patients with inflammatory bowel disease who present to the emergency department: a systematic review and meta-analysis [0.03%]
急诊患者内镜检查发现炎症性肠病的系统评价和荟萃分析
Althaf Azward,Gabriella Ripstein,Edgard Medawar et al.
Althaf Azward et al.
Background: The diagnostic yield of abdominal computed tomographic (CT) imaging for patients with inflammatory bowel disease (IBD) in the emergency department (ED) is unclear. We aimed to estimate the prevalence of IBD an...
Response to: The Long Game in Ulcerative Colitis: Mirikizumab's Four-Year Outcomes [0.03%]
对溃疡性结肠炎长期管理：Mirikizumab四年研究结果_RESPONSE
David B Clemow
David B Clemow
Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells [0.03%]
溃疡性结肠炎患者乌司奴单抗耐药与一类促炎症黏膜调节T细胞改变相关
Kristi C Briggs,Ada Tam,Lara Chaaban et al.
Kristi C Briggs et al.
Background: Ustekinumab is a monoclonal antibody therapy targeting interleukin-12 and interleukin-23 for the treatment of inflammatory bowel diseases, including ulcerative colitis (UC). While these pathways remain quite a...
Longitudinal TCR repertoires in ulcerative colitis patients show features distinguishing disease states [0.03%]
溃疡性结肠炎患者的纵向TCR库在不同疾病状态下表现出不同的特征
Sabahat Rahman,Beiya Xu,Matthew Farah et al.
Sabahat Rahman et al.
Background: Ulcerative colitis (UC) affects an estimated 10 million people worldwide. The exact etiology of the disease is unknown, but T-cell dysregulation and aberrant activation is associated with UC-prompting research...
The morphology paradox in pediatric IBD organoids: a path from transcriptomic heterogeneity to clinical utility [0.03%]
儿科IBD类器官的形态学悖论：从转录组异质性到临床应用之路
Linfan Qi,Zijian Wu,Hui Cai
Linfan Qi
Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping review [0.03%]
关于炎症性肠病妊娠期医疗保健质量的系统综述研究
Simone Chin,Kathryn Demase,Crispin Corte et al.
Simone Chin et al.
Inflammatory bowel disease (IBD) is associated with an increased risk of adverse pregnancy outcomes. The number of individuals affected by IBD during their reproductive years is expected to increase in parallel with rising disease prevalenc...
Early immunomodulator therapy reduces the risk of intestinal resection in Crohns disease: a systematic review and meta-analysis [0.03%]
早期免疫调节治疗可降低克罗恩病肠切除手术风险：系统性回顾和meta分析
Jiyoung Yoon,Yu Kyung Jun,Hye Sun Lee et al.
Jiyoung Yoon et al.
Background: The optimal timing for initiating immunomodulators (IMs) in Crohns disease (CD) remains unclear. We assessed whether early IM therapy reduces the risk of intestinal resection. ...
Skin-deep connections: likelihood of skin-scarring history in patients with stricturing/penetrating Crohn disease compared with patients with nonstricturing/nonpenetrating disease and non-inflammatory bowel disease controls [0.03%]
表浅联系：与非狭窄/穿透性克罗恩病患者及非炎症性肠病对照组相比，皮肤瘢痕史在狭窄/穿透性克罗恩病患者中的发生率研究
Mustafa Mohamedrashed,Saiumaeswar Yogakanthi,Ayushi Chauhan et al.
Mustafa Mohamedrashed et al.
Patients with stricturing/penetrating Crohn disease had significantly more hypertrophic/keloid scars than those with nonstricturing disease in this cross-sectional proof-of-concept study, suggesting potential shared fibrotic mechanisms betw...
Transitioning to adult care for patients with IBD: the impact of a structured IBD transition program on service engagement [0.03%]
克罗恩病和溃疡性结肠炎结构化过渡方案的效果分析
Jayne Doherty,Ciaran Hurley,Parker Girod et al.
Jayne Doherty et al.
Background and aims: The British Society of Gastroenterology recommend use of structured transition programs to improve control of chronic gastrointestinal disease in adolescents. We sought to determine the impact of atte...